Sangamo Therapeutics (SGMOQ) Other Operating Expenses (2012 - 2025)

Sangamo Therapeutics' Other Operating Expenses history runs 5 years deep, the most recent figure standing at $13.2 million for Q4 2025.

• On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $13.2 million in Q4 2025; TTM through Dec 2025 was $13.2 million, a 139.72% increase from a year earlier, with the FY2025 full-year figure at $13.2 million, up 139.72% from the prior year.
• Other Operating Expenses climbed to $13.2 million in Q4 2025 per SGMOQ's latest filing, from $1.2 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $58.6 million in Q1 2023 and bottomed at $296000.0 in Q4 2023.
• The 3-year median for Other Operating Expenses is $13.2 million (2025), against an average of $24.8 million.
• Biggest YoY gain for Other Operating Expenses was 92.57% in 2024; the steepest drop was 97.72% in 2024.
• Year by year, Other Operating Expenses stood at $296000.0 in 2023, then soared by 295.95% to $1.2 million in 2024, then soared by 1029.27% to $13.2 million in 2025.
• Per Business Quant, the three latest SGMOQ Other Operating Expenses figures stand at $13.2 million (Q4 2025), $1.2 million (Q2 2024), and $4.3 million (Q1 2024).